Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualised drug therapy based on pharmacogenomics: focus on carboxylesterase 1 (CES1)
2011-004815-22Phase 4Completed
- Sponsor
- Institute of Biological Psychiatry
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylphenidate and trandolapril (2 arms), sponsored by Institute of Biological Psychiatry. Primary endpoint: Pharmacokinetic variables of methylphenidate and trandolapril. Started Oct 2011; status: completed.
02
Drugs
methylphenidatetrandolapril
Beyond the preview
Go deeper on 2011-004815-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004815-22.